Developmental origins of genotype-phenotype correlations in chronic diseases of old age

Aging and Disease

Volumn 3, Issue 5, 2012, Pages 385-403

  McCormack, Shana ^a,b   Xia, Qianghua ^a   Grant, Struan F A ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Association; Childhood; Disease; Genetic; Late onset

Indexed keywords

EID: 84896751792     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (173)

1. Visscher PM, Brown MA, McCarthy MI and Yang J (2012). Five years of GWAS discovery. American journal of human genetics, 90: 7-24
2. Barker DJ (2012). Sir Richard Doll Lecture. Developmental origins of chronic disease. Public health, 126: 185-189
3. Gluckman PD, Hanson MA, Cooper C and Thornburg KL (2008). Effect of in utero and early-life conditions on adult health and disease. The New England journal of medicine, 359: 61-73
4. Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S, Barrett-Connor E, Bhargava SK, Birgisdottir BE, et al (2008). Birth weight and risk of type 2 diabetes: a systematic review. JAMA, 300: 2886-2897
5. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R and Ellard S (1998). Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nature genetics, 19: 268-270
6. Hattersley AT and Tooke JE (1999). The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet, 353: 1789-1792
7. Weedon MN, Frayling TM, Shields B, Knight B, Turner T, Metcalf BS, et al (2005). Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene. Diabetes, 54: 576-581
8. Weedon MN, Clark VJ, Qian Y, Ben-Shlomo Y, Timpson N, Ebrahim S, et al (2006). A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. American journal of human genetics, 79: 991-1001
9. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al (2006). Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature genetics, 38: 320-323
10. Yi F, Brubaker PL and Jin T (2005). TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. The Journal of biological chemistry, 280: 1457-1464
11. Freathy RM, Weedon MN, Bennett A, Hypponen E, Relton CL, Knight B, et al (2007). Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals. American journal of human genetics, 80: 1150-1161
12. Mook-Kanamori DO, de Kort SW, van Duijn CM, Uitterlinden AG, Hofman A, Moll HA, Steegers EA, Hokken-Koelega AC and Jaddoe VW (2009). Type 2 diabetes gene TCF7L2 polymorphism is not associated with fetal and postnatal growth in two birth cohort studies. BMC medical genetics, 10: 67
13. Pulizzi N, Lyssenko V, Jonsson A, Osmond C, Laakso M, Kajantie E, Barker DJ, Groop LC and Eriksson JG (2009). Interaction between prenatal growth and high-risk genotypes in the development of type 2 diabetes. Diabetologia, 52: 825-829
14. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM and Altshuler D (2006). TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. The New England journal of medicine, 355: 241-250
15. de Kort SW, Mook-Kanamori DO, Jaddoe VW and Hokken-Koelega AC (2010). Interactions between TCF7L2 genotype and growth hormone-induced changes in glucose homeostasis in small for gestational age children. Clinical endocrinology, 72: 47-52
16. Reinehr T, Friedel S, Mueller TD, Toschke AM, Hebebrand J and Hinney A (2008). Evidence for an influence of TCF7L2 polymorphism rs7903146 on insulin resistance and sensitivity indices in overweight children and adolescents during a lifestyle intervention. Int J Obes (Lond), 32: 1521-1524
17. Freathy RM, Bennett AJ, Ring SM, Shields B, Groves CJ, Timpson NJ, Weedon MN, Zeggini E, Lindgren CM, Lango H, Perry JR, Pouta A, Ruokonen A, Hypponen E, Power C, Elliott P, Strachan DP, Jarvelin MR, Smith GD, McCarthy MI, Frayling TM and Hattersley AT (2009). Type 2 diabetes risk alleles are associated with reduced size at birth. Diabetes, 58: 1428-1433
18. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, et al (2007). A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nature genetics, 39: 770-775
19. Zhao J, Li M, Bradfield JP, Wang K, Zhang H, Sleiman P, Kim CE, Annaiah K, Glaberson W, Glessner JT, Otieno FG, Thomas KA, Garris M, Hou C, Frackelton EC, Chiavacci RM, Berkowitz RI, Hakonarson H and Grant SF (2009). Examination of type 2 diabetes loci implicates CDKAL1 as a birth weight gene. Diabetes, 58: 2414-2418
20. Morgan AR, Thompson JM, Murphy R, Black PN, Lam WJ, Ferguson LR and Mitchell EA (2010). Obesity and diabetes genes are associated with being born small for gestational age: results from the Auckland Birthweight Collaborative study. BMC medical genetics, 11: 125
21. Andersson EA, Harder MN, Pilgaard K, Pisinger C, Stancakova A, Kuusisto J, Grarup N, Faerch K, Poulsen P, Witte DR, Jorgensen T, Vaag A, Laakso M, Pedersen O and Hansen T (2011). The birth weight lowering C-allele of rs900400 near LEKR1 and CCNL1 associates with elevated insulin release following an oral glucose challenge. PloS one, 6: e27096
22. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, et al (2012). Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nature genetics
23. Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, et al (2012). A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nature genetics, 44: 659-669
24. van Hoek M, Langendonk JG, de Rooij SR, Sijbrands EJ and Roseboom TJ (2009). Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism. Diabetes, 58: 1440-1444
25. Nicklas TA, Baranowski T, Cullen KW and Berenson G (2001). Eating patterns, dietary quality and obesity. J Am Coll Nutr, 20: 599-608
26. Whitaker RC, Wright JA, Pepe MS, Seidel KD and Dietz WH (1997). Predicting obesity in young adulthood from childhood and parental obesity. The New England journal of medicine, 337: 869-873
27. Parsons TJ, Power C, Logan S and Summerbell CD (1999). Childhood predictors of adult obesity: a systematic review. Int J Obes Relat Metab Disord, 23 Suppl 8: S1-107
28. Bradfield JP, Taal HR, Timpson NJ, Scherag A, Lecoeur C, Warrington NM, et al (2012). A genome-wide association meta-analysis identifies new childhood obesity loci. Nature genetics, 44: 526-531
29. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al (2007). A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 316: 889-894
30. Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P, et al (2007). Variation in FTO contributes to childhood obesity and severe adult obesity. Nature genetics, 39: 724-726
31. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA, Cunliffe S, McNeill LA, Galvanovskis J, Rorsman P, Robins P, Prieur X, Coll AP, Ma M, Jovanovic Z, Farooqi IS, Sedgwick B, Barroso I, Lindahl T, Ponting CP, Ashcroft FM, O'Rahilly S and Schofield CJ (2007). The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science, 318: 1469-1472
32. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, et al (2007). Genome-wide atlas of gene expression in the adult mouse brain. Nature, 445: 168-176
33. Cecil JE, Tavendale R, Watt P, Hetherington MM and Palmer CN (2008). An obesity-associated FTO gene variant and increased energy intake in children. The New England journal of medicine, 359: 2558-2566
34. Fox CS, Liu Y, White CC, Feitosa M, Smith AV, Heard-Costa N, et al (2012). Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. PLoS genetics, 8: e1002695
35. Andersson EA, Pilgaard K, Pisinger C, Harder MN, Grarup N, Faerch K, Sandholt C, Poulsen P, Witte DR, Jorgensen T, Vaag A, Pedersen O and Hansen T (2010). Do gene variants influencing adult adiposity affect birth weight? A population-based study of 24 loci in 4,744 Danish individuals. PloS one, 5: e14190
36. Manco M and Dallapiccola B (2012). Genetics of pediatric obesity. Pediatrics, 130: 123-133
37. Lopez-Bermejo A, Petry CJ, Diaz M, Sebastiani G, de Zegher F, Dunger DB and Ibanez L (2008). The association between the FTO gene and fat mass in humans develops by the postnatal age of two weeks. The Journal of clinical endocrinology and metabolism, 93: 1501-1505
38. Hardy R, Wills AK, Wong A, Elks CE, Wareham NJ, Loos RJ, Kuh D and Ong KK (2010). Life course variations in the associations between FTO and MC4R gene variants and body size. Human molecular genetics, 19: 545-552
39. Silverwood RJ, De Stavola BL, Cole TJ and Leon DA (2009). BMI peak in infancy as a predictor for later BMI in the Uppsala Family Study. Int J Obes (Lond), 33: 929-937
40. Wen X, Kleinman K, Gillman MW, Rifas-Shiman SL and Taveras EM (2012). Childhood body mass index trajectories: modeling, characterizing, pairwise correlations and socio-demographic predictors of trajectory characteristics. BMC medical research methodology, 12: 38
41. Rolland-Cachera MF, Deheeger M, Bellisle F, Sempe M, Guilloud-Bataille M and Patois E (1984). Adiposity rebound in children: a simple indicator for predicting obesity. The American journal of clinical nutrition, 39: 129-135
42. Rolland-Cachera MF, Deheeger M, Maillot M and Bellisle F (2006). Early adiposity rebound: causes and consequences for obesity in children and adults. Int J Obes (Lond), 30 Suppl 4: S11-17
43. Barker DJ, Osmond C, Forsen TJ, Kajantie E and Eriksson JG (2005). Trajectories of growth among children who have coronary events as adults. The New England journal of medicine, 353: 1802-1809
44. Sovio U, Mook-Kanamori DO, Warrington NM, Lawrence R, Briollais L, Palmer CN, Cecil J, Sandling JK, Syvanen AC, Kaakinen M, Beilin LJ, Millwood IY, Bennett AJ, Laitinen J, Pouta A, Molitor J, Davey Smith G, Ben-Shlomo Y, Jaddoe VW, Palmer LJ, Pennell CE, Cole TJ, McCarthy MI, Jarvelin MR and Timpson NJ (2011). Association between common variation at the FTO locus and changes in body mass index from infancy to late childhood: the complex nature of genetic association through growth and development. PLoS genetics, 7: e1001307
45. Freathy RM, Timpson NJ, Lawlor DA, Pouta A, Ben-Shlomo Y, Ruokonen A, Ebrahim S, Shields B, Zeggini E, Weedon MN, Lindgren CM, Lango H, Melzer D, Ferrucci L, Paolisso G, Neville MJ, Karpe F, Palmer CN, Morris AD, Elliott P, Jarvelin MR, Smith GD, McCarthy MI, Hattersley AT and Frayling TM (2008). Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes, 57: 1419-1426
46. Hertel JK, Johansson S, Sonestedt E, Jonsson A, Lie RT, Platou CG, Nilsson PM, Rukh G, Midthjell K, Hveem K, Melander O, Groop L, Lyssenko V, Molven A, Orho-Melander M and Njolstad PR (2011). FTO, type 2 diabetes, and weight gain throughout adult life: a meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes, 60: 1637-1644
47. Mei H, Chen W, Jiang F, He J, Srinivasan S, Smith EN, Schork N, Murray S and Berenson GS (2012). Longitudinal replication studies of GWAS risk SNPs influencing body mass index over the course of childhood and adulthood. PloS one, 7: e31470
48. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, et al (2008). Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nature genetics, 40: 768-775
49. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T and O'Rahilly S (2003). Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. The New England journal of medicine, 348: 1085-1095
50. Krakoff J, Ma L, Kobes S, Knowler WC, Hanson RL, Bogardus C and Baier LJ (2008). Lower metabolic rate in individuals heterozygous for either a frameshift or a functional missense MC4R variant. Diabetes, 57: 3267-3272
51. Metcalf BS, Hosking J, Fremeaux AE, Jeffery AN, Voss LD and Wilkin TJ (2011). BMI was right all along: taller children really are fatter (implications of making childhood BMI independent of height) EarlyBird 48. Int J Obes (Lond), 35: 541-547
52. Elks CE, Loos RJ, Hardy R, Wills AK, Wong A, Wareham NJ, Kuh D and Ong KK (2012). Adult obesity susceptibility variants are associated with greater childhood weight gain and a faster tempo of growth: the 1946 British Birth Cohort Study. The American journal of clinical nutrition, 95: 1150-1156
53. Martinelli CE, Keogh JM, Greenfield JR, Henning E, van der Klaauw AA, Blackwood A, O'Rahilly S, Roelfsema F, Camacho-Hubner C, Pijl H and Farooqi IS (2011). Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. The Journal of clinical endocrinology and metabolism, 96: E181-188
54. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J and Holly JM (2001). Height, leg length, and cancer risk: a systematic review. Epidemiologic reviews, 23: 313-342
55. Lawlor DA, Ebrahim S and Davey Smith G (2002). The association between components of adult height and Type II diabetes and insulin resistance: British Women's Heart and Health Study. Diabetologia, 45: 1097-1106
56. Zobel DP, Andreasen CH, Grarup N, Eiberg H, Sorensen TI, Sandbaek A, Lauritzen T, Borch-Johnsen K, Jorgensen T, Pedersen O and Hansen T (2009). Variants near MC4R are associated with obesity and influence obesity-related quantitative traits in a population of middle-aged people: studies of 14,940 Danes. Diabetes, 58: 757-764
57. Moran A, Jacobs DR, Jr., Steinberger J, Cohen P, Hong CP, Prineas R and Sinaiko AR (2002). Association between the insulin resistance of puberty and the insulin-like growth factor-I/growth hormone axis. The Journal of clinical endocrinology and metabolism, 87: 4817-4820
58. Elks CE, Perry JR, Sulem P, Chasman DI, Franceschini N, He C, et al (2010). Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nature genetics, 42: 1077-1085
59. Seidah NG, Benjannet S, Hamelin J, Mamarbachi AM, Basak A, Marcinkiewicz J, Mbikay M, Chretien M and Marcinkiewicz M (1999). The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1. Annals of the New York Academy of Sciences, 885: 57-74
60. Krude H, Biebermann H, Luck W, Horn R, Brabant G and Gruters A (1998). Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature genetics, 19: 155-157
61. Sutton BS, Langefeld CD, Williams AH, Norris JM, Saad MF, Haffner SM and Bowden DW (2005). Association of proopiomelanocortin gene polymorphisms with obesity in the IRAS family study. Obesity research, 13: 1491-1498
62. Chen Y, Snieder H, Wang X, Kaviya B, McCaffrey C, Spector TD, Carter ND and O'Dell SD (2005). Proopiomelanocortin gene variants are associated with serum leptin and body fat in a normal female population. European journal of human genetics: EJHG, 13: 772-780
63. Krude H, Biebermann H, Schnabel D, Tansek MZ, Theunissen P, Mullis PE and Gruters A (2003). Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. The Journal of clinical endocrinology and metabolism, 88: 4633-4640
64. Gudbjartsson DF, Walters GB, Thorleifsson G, Stefansson H, Halldorsson BV, Zusmanovich P, et al (2008). Many sequence variants affecting diversity of adult human height. Nature genetics, 40: 609-615
65. Jackson RS, Creemers JW, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, Hutton JC and O'Rahilly S (1997). Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nature genetics, 16: 303-306
66. Farooqi IS, Volders K, Stanhope R, Heuschkel R, White A, Lank E, Keogh J, O'Rahilly S and Creemers JW (2007). Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. The Journal of clinical endocrinology and metabolism, 92: 3369-3373
67. Benzinou M, Creemers JW, Choquet H, Lobbens S, Dina C, Durand E, et al (2008). Common nonsynonymous variants in PCSK1 confer risk of obesity. Nature genetics, 40: 943-945
68. Creemers JW, Choquet H, Stijnen P, Vatin V, Pigeyre M, Beckers S, Meulemans S, Than ME, Yengo L, Tauber M, Balkau B, Elliott P, Jarvelin MR, Van Hul W, Van Gaal L, Horber F, Pattou F, Froguel P and Meyre D (2012). Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes, 61: 383-390
69. Kilpelainen TO, Bingham SA, Khaw KT, Wareham NJ and Loos RJ (2009). Association of variants in the PCSK1 gene with obesity in the EPIC-Norfolk study. Human molecular genetics, 18: 3496-3501
70. Zhu X, Zhou A, Dey A, Norrbom C, Carroll R, Zhang C, Laurent V, Lindberg I, Ugleholdt R, Holst JJ and Steiner DF (2002). Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proceedings of the National Academy of Sciences of the United States of America, 99: 10293-10298
71. Strawbridge RJ, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, Rybin D, et al (2011). Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes, 60: 2624-2634
72. Jackson RS, Creemers JW, Farooqi IS, Raffin-Sanson ML, Varro A, Dockray GJ, Holst JJ, Brubaker PL, Corvol P, Polonsky KS, Ostrega D, Becker KL, Bertagna X, Hutton JC, White A, Dattani MT, Hussain K, Middleton SJ, Nicole TM, Milla PJ, Lindley KJ and O'Rahilly S (2003). Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. The Journal of clinical investigation, 112: 1550-1560
73. Gjesing AP, Vestmar MA, Jorgensen T, Heni M, Holst JJ, Witte DR, Hansen T and Pedersen O (2011). The effect of PCSK1 variants on waist, waist-hip ratio and glucose metabolism is modified by sex and glucose tolerance status. PloS one, 6: e23907
74. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH and Reichardt LF (2003). Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nature neuroscience, 6: 736-742
75. Gray J, Yeo GS, Cox JJ, Morton J, Adlam AL, Keogh JM, Yanovski JA, El Gharbawy A, Han JC, Tung YC, Hodges JR, Raymond FL, O'Rahilly S and Farooqi IS (2006). Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes, 55: 3366-3371
76. Yeo GS, Connie Hung CC, Rochford J, Keogh J, Gray J, Sivaramakrishnan S, O'Rahilly S and Farooqi IS (2004). A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nature neuroscience, 7: 1187-1189
77. Han JC, Liu QR, Jones M, Levinn RL, Menzie CM, Jefferson-George KS, Adler-Wailes DC, Sanford EL, Lacbawan FL, Uhl GR, Rennert OM and Yanovski JA (2008). Brain-derived neurotrophic factor and obesity in the WAGR syndrome. The New England journal of medicine, 359: 918-927
78. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM and Jaenisch R (2001). Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol, 15: 1748-1757
79. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, et al (2010). Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature genetics, 42: 937-948
80. Zhao J, Bradfield JP, Zhang H, Sleiman PM, Kim CE, Glessner JT, Deliard S, Thomas KA, Frackelton EC, Li M, Chiavacci RM, Berkowitz RI, Hakonarson H and Grant SF (2011). Role of BMI-associated loci identified in GWAS meta-analyses in the context of common childhood obesity in European Americans. Obesity (Silver Spring), 19: 2436-2439
81. Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, Fischer CP, Lindegaard B, Petersen AM, Taudorf S, Secher NH, Pilegaard H, Bruunsgaard H and Pedersen BK (2007). Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia, 50: 431-438
82. Sandholt CH, Vestmar MA, Bille DS, Borglykke A, Almind K, Hansen L, Sandbaek A, Lauritzen T, Witte D, Jorgensen T, Pedersen O and Hansen T (2011). Studies of metabolic phenotypic correlates of 15 obesity associated gene variants. PloS one, 6: e23531
83. Pruunsild P, Kazantseva A, Aid T, Palm K and Timmusk T (2007). Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics, 90: 397-406
84. Bachmann-Gagescu R, Mefford HC, Cowan C, Glew GM, Hing AV, Wallace S, Bader PI, Hamati A, Reitnauer PJ, Smith R, Stockton DW, Muhle H, Helbig I, Eichler EE, Ballif BC, Rosenfeld J and Tsuchiya KD (2010). Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genetics in medicine: official journal of the American College of Medical Genetics, 12: 641-647
85. Thomsen M, Dahl M, Tybjaerg-Hansen A and Nordestgaard BG (2012). beta2-adrenergic receptor Thr164Ile polymorphism, obesity, and diabetes: comparison with FTO, MC4R, and TMEM18 polymorphisms in more than 64,000 individuals. The Journal of clinical endocrinology and metabolism, 97: E1074-1079
86. McCaffery JM, Papandonatos GD, Peter I, Huggins GS, Raynor HA, Delahanty LM, Cheskin LJ, Balasubramanyam A, Wagenknecht LE and Wing RR (2012). Obesity susceptibility loci and dietary intake in the Look AHEAD Trial. The American journal of clinical nutrition, 95: 1477-1486
87. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L and Arner P (1997). Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. The Journal of clinical investigation, 100: 3005-3013
88. Lou Y, Liu J, Huang Y, Liu J, Wang Z, Liu Y, Li Z, Li Y, Xie Y and Wen S (2010). A46G and C79G polymorphisms in the beta2-adrenergic receptor gene (ADRB2) and essential hypertension risk: a meta-analysis. Hypertension research: official journal of the Japanese Society of Hypertension, 33: 1114-1123
89. Zuk O, Hechter E, Sunyaev SR and Lander ES (2012). The mystery of missing heritability: Genetic interactions create phantom heritability. Proceedings of the National Academy of Sciences of the United States of America, 109: 1193-1198
90. Belsky DW, Moffitt TE, Houts R, Bennett GG, Biddle AK, Blumenthal JA, Evans JP, Harrington H, Sugden K, Williams B, Poulton R and Caspi A (2012). Polygenic risk, rapid childhood growth, and the development of obesity: evidence from a 4-decade longitudinal study. Archives of pediatrics & adolescent medicine, 166: 515-521
91. Mumby HS, Elks CE, Li S, Sharp SJ, Khaw KT, Luben RN, Wareham NJ, Loos RJ and Ong KK (2011). Mendelian Randomisation Study of Childhood BMI and Early Menarche. Journal of obesity, 2011: 180729
92. den Hoed M, Ekelund U, Brage S, Grontved A, Zhao JH, Sharp SJ, Ong KK, Wareham NJ and Loos RJ (2010). Genetic susceptibility to obesity and related traits in childhood and adolescence: influence of loci identified by genome-wide association studies. Diabetes, 59: 2980-2988
93. Somia NV, Schmitt MJ, Vetter DE, Van Antwerp D, Heinemann SF and Verma IM (1999). LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proceedings of the National Academy of Sciences of the United States of America, 96: 12667-12672
94. Zhou G, Bao ZQ and Dixon JE (1995). Components of a new human protein kinase signal transduction pathway. The Journal of biological chemistry, 270: 12665-12669
95. Kilpelainen TO, den Hoed M, Ong KK, Grontved A, Brage S, Jameson K, Cooper C, Khaw KT, Ekelund U, Wareham NJ and Loos RJ (2011). Obesity-susceptibility loci have a limited influence on birth weight: a meta-analysis of up to 28,219 individuals. The American journal of clinical nutrition, 93: 851-860
96. Kanis JA, Melton LJ, 3rd, Christiansen C, Johnston CC and Khaltaev N (1994). The diagnosis of osteoporosis. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research, 9: 1137-1141
97. Cummings SR, Marcus R, Palermo L, Ensrud KE and Genant HK (1994). Does estimating volumetric bone density of the femoral neck improve the prediction of hip fracture? A prospective study. Study of Osteoporotic Fractures Research Group. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research, 9: 1429-1432
98. Kanis JA, Johnell O, Oden A, Johansson H and McCloskey E (2008). FRAX and the assessment of fracture probability in men and women from the UK. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 19: 385-397
99. Seeman E and Delmas PD (2006). Bone quality--the material and structural basis of bone strength and fragility. The New England journal of medicine, 354: 2250-2261
100. Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic V and Weaver C (2000). Peak bone mass. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 11: 985-1009
101. Rosen CJ (2000). Pathogenesis of osteoporosis. Bailliere's best practice & research. Clinical endocrinology & metabolism, 14: 181-193
102. Ferrari S (2008). Human genetics of osteoporosis. Best practice & research. Clinical endocrinology & metabolism, 22: 723-735
103. Ferrari S, Rizzoli R, Slosman D and Bonjour JP (1998). Familial resemblance for bone mineral mass is expressed before puberty. The Journal of clinical endocrinology and metabolism, 83: 358-361
104. Michaelsson K, Melhus H, Ferm H, Ahlbom A and Pedersen NL (2005). Genetic liability to fractures in the elderly. Archives of internal medicine, 165: 1825-1830
105. Rosen CJ (2005). Clinical practice. Postmenopausal osteoporosis. The New England journal of medicine, 353: 595-603
106. Gafni RI and Baron J (2007). Childhood bone mass acquisition and peak bone mass may not be important determinants of bone mass in late adulthood. Pediatrics, 119 Suppl 2: S131-136
107. Javaid MK and Cooper C (2002). Prenatal and childhood influences on osteoporosis. Best practice & research. Clinical endocrinology & metabolism, 16: 349-367
108. Schauberger CW and Pitkin RM (1979). Maternal-perinatal calcium relationships. Obstetrics and gynecology, 53: 74-76
109. Cooper C, Cawley M, Bhalla A, Egger P, Ring F, Morton L and Barker D (1995). Childhood growth, physical activity, and peak bone mass in women. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research, 10: 940-947
110. Cooper C, Fall C, Egger P, Hobbs R, Eastell R and Barker D (1997). Growth in infancy and bone mass in later life. Annals of the rheumatic diseases, 56: 17-21
111. Cooper C, Westlake S, Harvey N, Javaid K, Dennison E and Hanson M (2006). Review: developmental origins of osteoporotic fracture. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 17: 337-347
112. Bass S, Delmas PD, Pearce G, Hendrich E, Tabensky A and Seeman E (1999). The differing tempo of growth in bone size, mass, and density in girls is region-specific. The Journal of clinical investigation, 104: 795-804
113. Bailey DA, McKay HA, Mirwald RL, Crocker PR and Faulkner RA (1999). A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research, 14: 1672-1679
114. Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC and Bonjour JP (1992). Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. The Journal of clinical endocrinology and metabolism, 75: 1060-1065
115. Bonjour JP, Theintz G, Law F, Slosman D and Rizzoli R (1994). Peak bone mass. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 4 Suppl 1: 7-13
116. Wang Q and Seeman E (2008). Skeletal growth and peak bone strength. Best practice & research. Clinical endocrinology & metabolism, 22: 687-700
117. Gilsanz V and Wren T (2007). Assessment of bone acquisition in childhood and adolescence. Pediatrics, 119 Suppl 2: S145-149
118. Gordon CM, Bachrach LK, Carpenter TO, Crabtree N, El-Hajj Fuleihan G, Kutilek S, Lorenc RS, Tosi LL, Ward KA, Ward LM and Kalkwarf HJ (2008). Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions. Journal of clinical densitometry: the official journal of the International Society for Clinical Densitometry, 11: 43-58
119. Richards JB, Kavvoura FK, Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, et al (2009). Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Annals of internal medicine, 151: 528-537
120. Uitterlinden AG, Ralston SH, Brandi ML, Carey AH, Grinberg D, Langdahl BL, et al (2006). The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Annals of internal medicine, 145: 255-264
121. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Snorradottir S, Center JR, Nguyen TV, Alexandersen P, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U and Stefansson K (2009). New sequence variants associated with bone mineral density. Nature genetics, 41: 15-17
122. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U and Stefansson K (2008). Multiple genetic loci for bone mineral density and fractures. The New England journal of medicine, 358: 2355-2365
123. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumanduri V, Moorhouse M, van Meurs JB, Hofman A, Pols HA, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukas P, Uitterlinden AG and Spector TD (2008). Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet, 371: 1505-1512
124. Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, Ntzani EE, Oei L, Albagha OM, et al (2012). Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nature genetics, 44: 491-501
125. Richards JB, Zheng HF and Spector TD (2012). Genetics of osteoporosis from genome-wide association studies: advances and challenges. Nature reviews. Genetics, 13: 576-588
126. Timpson NJ, Tobias JH, Richards JB, Soranzo N, Duncan EL, Sims AM, Whittaker P, Kumanduri V, Zhai G, Glaser B, Eisman J, Jones G, Nicholson G, Prince R, Seeman E, Spector TD, Brown MA, Peltonen L, Smith GD, Deloukas P and Evans DM (2009). Common variants in the region around Osterix are associated with bone mineral density and growth in childhood. Human molecular genetics, 18: 1510-1517
127. Gao Y, Jheon A, Nourkeyhani H, Kobayashi H and Ganss B (2004). Molecular cloning, structure, expression, and chromosomal localization of the human Osterix (SP7) gene. Gene, 341: 101-110
128. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR and de Crombrugghe B (2002). The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell, 108: 17-29
129. Lapunzina P, Aglan M, Temtamy S, Caparros-Martin JA, Valencia M, Leton R, Martinez-Glez V, Elhossini R, Amr K, Vilaboa N and Ruiz-Perez VL (2010). Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. American journal of human genetics, 87: 110-114
130. Zhao J, Bradfield JP, Li M, Zhang H, Mentch FD, Wang K, Sleiman PM, Kim CE, Glessner JT, Frackelton EC, Chiavacci RM, Berkowitz RI, Zemel BS, Hakonarson H and Grant SF (2011). BMD-associated variation at the Osterix locus is correlated with childhood obesity in females. Obesity (Silver Spring), 19: 1311-1314
131. Rauch F, Lalic L, Roughley P and Glorieux FH (2010). Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I. European journal of human genetics: EJHG, 18: 642-647
132. Grant SF, Reid DM, Blake G, Herd R, Fogelman I and Ralston SH (1996). Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nature genetics, 14: 203-205
133. Mann V, Hobson EE, Li B, Stewart TL, Grant SF, Robins SP, Aspden RM and Ralston SH (2001). A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. The Journal of clinical investigation, 107: 899-907
134. Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FE, Grant SF, Hofman A, van Leeuwen JP, Pols HA and Ralston SH (1998). Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. The New England journal of medicine, 338: 1016-1021
135. Blades HZ, Arundel P, Carlino WA, Dalton A, Crook JS, Freeman JV and Bishop NJ (2010). Collagen gene polymorphisms influence fracture risk and bone mass acquisition during childhood and adolescent growth. Bone, 47: 989-994
136. Willing MC, Torner JC, Burns TL, Janz KF, Marshall T, Gilmore J, Deschenes SP, Warren JJ and Levy SM (2003). Gene polymorphisms, bone mineral density and bone mineral content in young children: the Iowa Bone Development Study. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 14: 650-658
137. Suuriniemi M, Mahonen A, Kovanen V, Alen M and Cheng S (2003). Relation of PvuII site polymorphism in the COL1A2 gene to the risk of fractures in prepubertal Finnish girls. Physiological genomics, 14: 217-224
138. Tao C, Garnett S, Petrauskas V and Cowell CT (1999). No association was found between collagen alphaI type 1 gene and bone density in prepubertal children. The Journal of clinical endocrinology and metabolism, 84: 4293-4294
139. Kristjansson K, Rut AR, Hewison M, O'Riordan JL and Hughes MR (1993). Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3. The Journal of clinical investigation, 92: 12-16
140. Keen RW, Egger P, Fall C, Major PJ, Lanchbury JS, Spector TD and Cooper C (1997). Polymorphisms of the vitamin D receptor, infant growth, and adult bone mass. Calcified tissue international, 60: 233-235
141. Dennison EM, Arden NK, Keen RW, Syddall H, Day IN, Spector TD and Cooper C (2001). Birthweight, vitamin D receptor genotype and the programming of osteoporosis. Paediatric and perinatal epidemiology, 15: 211-219
142. Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA and Bonjour JP (1995). Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. Lancet, 345: 423-424
143. Duncan EL, Brown MA, Sinsheimer J, Bell J, Carr AJ, Wordsworth BP and Wass JA (1999). Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research, 14: 1993-1999
144. Vilarino-Guell C, Miles LJ, Duncan EL, Ralston SH, Compston JE, Cooper C, Langdahl BL, Maclelland A, Pols HA, Reid DM, Uitterlinden AG, Steer CD, Tobias JH, Wass JA and Brown MA (2007). PTHR1 polymorphisms influence BMD variation through effects on the growing skeleton. Calcified tissue international, 81: 270-278
145. Paternoster L, Ohlsson C, Sayers A, Vandenput L, Lorentzon M, Evans DM and Tobias JH (2010). OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon longitudinal study of parents and children and gothenburg osteoporosis and obesity determinants cohorts. The Journal of clinical endocrinology and metabolism, 95: 3940-3948
146. Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Benichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, De Vernejoul MC, Bollerslev J and Van Hul W (2003). Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. American journal of human genetics, 72: 763-771
147. van Meurs JB, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K, et al (2008). Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA, 299: 1277-1290
148. Koay MA, Tobias JH, Leary SD, Steer CD, Vilarino-Guell C and Brown MA (2007). The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood. Calcified tissue international, 81: 1-9
149. Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R and Antonarakis SE (2004). Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. American journal of human genetics, 74: 866-875
150. Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, Langdahl B, van Meurs JB, Mosekilde L, Scollen S, Albagha OM, Bustamante M, Carey AH, Dunning AM, Enjuanes A, van Leeuwen JP, Mavilia C, Masi L, McGuigan FE, Nogues X, Pols HA, Reid DM, Schuit SC, Sherlock RE and Uitterlinden AG (2004). Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA: the journal of the American Medical Association, 292: 2105-2114
151. Boot AM, van der Sluis IM, de Muinck Keizer-Schrama SM, van Meurs JB, Krenning EP, Pols HA and Uitterlinden AG (2004). Estrogen receptor alpha gene polymorphisms and bone mineral density in healthy children and young adults. Calcified tissue international, 74: 495-500
152. Tobias JH, Steer CD, Vilarino-Guell C and Brown MA (2007). Estrogen receptor alpha regulates area-adjusted bone mineral content in late pubertal girls. The Journal of clinical endocrinology and metabolism, 92: 641-647
153. Niu T and Rosen CJ (2005). The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene, 361: 38-56
154. Zheng HF, Tobias JH, Duncan E, Evans DM, Eriksson J, Paternoster L, et al (2012). WNT16 Influences Bone Mineral Density, Cortical Bone Thickness, Bone Strength, and Osteoporotic Fracture Risk. PLoS genetics, 8: e1002745
155. Medina-Gomez C, Kemp JP, Estrada K, Eriksson J, Liu J, Reppe S, Evans DM, et al (2012). Meta-Analysis of Genome-Wide Scans for Total Body BMD in Children and Adults Reveals Allelic Heterogeneity and Age-Specific Effects at the WNT16 Locus. PLoS genetics, 8: e1002718
156. Ladouceur M, Leslie WD, Dastani Z, Goltzman D and Richards JB (2010). An efficient paradigm for genetic epidemiology cohort creation. PloS one, 5: e14045
157. DiVasta AD and Gordon CM (2006). Bone health in adolescents. Adolescent medicine clinics, 17: 639-652; abstract xi
158. Cooke RW, Lucas A, Yudkin PL and Pryse-Davies J (1977). Head circumference as an index of brain weight in the fetus and newborn. Early human development, 1: 145-149
159. Winick M and Rosso P (1969). Head circumference and cellular growth of the brain in normal and marasmic children. The Journal of pediatrics, 74: 774-778
160. Pryor HB and Thelander H (1968). Abnormally small head size and intellect in children. The Journal of pediatrics, 73: 593-598
161. Desch LW, Anderson SK and Snow JH (1990). Relationship of head circumference to measures of school performance. Clinical pediatrics, 29: 389-392
162. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, et al (2010). Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature, 467: 832-838
163. Ikram MA, Fornage M, Smith AV, Seshadri S, Schmidt R, Debette S, Vrooman HA, et al (2012). Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet, 44: 539-544
164. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, et al (2009). Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet, 41: 1308-1312
165. Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simon-Sanchez J, Schulte C, Lesage S, Sveinbjornsdottir S, Stefansson K, Martinez M, Hardy J, Heutink P, Brice A, Gasser T, Singleton AB and Wood NW (2011). Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet, 377: 641-649
166. Webb A, Miller B, Bonasera S, Boxer A, Karydas A and Wilhelmsen KC (2008). Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders. Arch Neurol, 65: 1473-1478
167. Taal HR, St Pourcain B, Thiering E, Das S, Mook-Kanamori DO, Warrington NM, et al (2012). Common variants at 12q15 and 12q24 are associated with infant head circumference. Nat Genet, 44: 532-538
168. Loftus EV, Jr. (2004). Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology, 126: 1504-1517
169. Lakatos PL (2006). Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World journal of gastroenterology: WJG, 12: 6102-6108
170. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J, Gunther S, Prescott NJ, Onnie CM, Hasler R, Sipos B, Folsch UR, Lengauer T, Platzer M, Mathew CG, Krawczak M and Schreiber S (2007). A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nature genetics, 39: 207-211
171. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL and Cho JH (2006). A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science, 314: 1461-1463
172. Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PM, Imielinski M, Guthery SL, et al (2008). Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nature genetics, 40: 1211-1215
173. Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, Dubinsky M, et al (2009). Common variants at five new loci associated with early-onset inflammatory bowel disease. Nature genetics, 41: 1335-1340